New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

by La Jolla Institute for ImmunologyGenetic differences leave immune cells at a disadvantage. Credit: La Jolla Institute for ImmunologyNew research shows how genetic variations linked to severe c
Immunology & Rheumatology April 10,2024
COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

by La Jolla Institute for ImmunologyGenetic differences leave immune cells at a disadvantage. Credit: La Jolla Institute for ImmunologyNew research shows how genetic variations linked to severe c
Immunology & Rheumatology April 10,2024
Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

by University of Alabama at BirminghamCredit: University of Alabama at BirminghamPreclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive resul
Immunology & Rheumatology April 10,2024
Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

by University of Alabama at BirminghamCredit: University of Alabama at BirminghamPreclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive resul
Immunology & Rheumatology April 10,2024
How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

by Università della Svizzera italianaCredit: Università della Svizzera italianaAn international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della S
Public Health & Prevention April 10,2024
How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

by Università della Svizzera italianaCredit: Università della Svizzera italianaAn international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della S
Public Health & Prevention April 10,2024
Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

by Stefan Zorn, Medizinische Hochschule HannoverLevel of Problems Experienced by Patients. Patients were able to provide levels on a scale from 0 to 5 (0 = no problems, 5 = unable/extreme problems) fo
Public Health & Prevention April 10,2024
Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

by Stefan Zorn, Medizinische Hochschule HannoverLevel of Problems Experienced by Patients. Patients were able to provide levels on a scale from 0 to 5 (0 = no problems, 5 = unable/extreme problems) fo
Public Health & Prevention April 10,2024
Simple test for COVID-19 could prioritize treatments for individuals most at risk

Simple test for COVID-19 could prioritize treatments for individuals most at risk

by Flinders UniversitySROC curve with 95% confidence region and prediction region for the SII towards prediction of severe disease or mortality. Credit:Frontiers in Immunology(2023).
Public Health & Prevention April 10,2024
Simple test for COVID-19 could prioritize treatments for individuals most at risk

Simple test for COVID-19 could prioritize treatments for individuals most at risk

by Flinders UniversitySROC curve with 95% confidence region and prediction region for the SII towards prediction of severe disease or mortality. Credit:Frontiers in Immunology(2023).
Public Health & Prevention April 10,2024
COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th
Public Health & Prevention April 10,2024
COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th
Public Health & Prevention April 10,2024
COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

by University of Utah Health SciencesCredit: CC0 Public DomainWhile it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available t
Public Health & Prevention April 10,2024
COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

by University of Utah Health SciencesCredit: CC0 Public DomainWhile it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available t
Public Health & Prevention April 10,2024
COVID-19: Vaccination and infection found to trigger differential immune responses

COVID-19: Vaccination and infection found to trigger differential immune responses

by Lena Bösch,University of GöttingenCredit: CC0 Public DomainIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scient
Public Health & Prevention April 10,2024
COVID-19: Vaccination and infection found to trigger differential immune responses

COVID-19: Vaccination and infection found to trigger differential immune responses

by Lena Bösch,University of GöttingenCredit: CC0 Public DomainIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scient
Public Health & Prevention April 10,2024
COVID-19: Not all patients develop protective antibodies

COVID-19: Not all patients develop protective antibodies

by Medical University of ViennaCredit: Pixabay/CC0 Public DomainA laboratory test developed by a study group from MedUni Vienna can determine whether COVID-19 patients develop protective antibodi
Public Health & Prevention April 10,2024
COVID-19: Not all patients develop protective antibodies

COVID-19: Not all patients develop protective antibodies

by Medical University of ViennaCredit: Pixabay/CC0 Public DomainA laboratory test developed by a study group from MedUni Vienna can determine whether COVID-19 patients develop protective antibodi
Public Health & Prevention April 10,2024
COVID-19 in babies: What to expect

COVID-19 in babies: What to expect

by Shidan Tosif and Sarah McNab,The ConversationCredit: Sandeep Kashyap from PexelsParents are understandably worried about what would happen if their infant caught COVID-19. Babies may be consi
Public Health & Prevention April 10,2024
COVID-19 in babies: What to expect

COVID-19 in babies: What to expect

by Shidan Tosif and Sarah McNab,The ConversationCredit: Sandeep Kashyap from PexelsParents are understandably worried about what would happen if their infant caught COVID-19. Babies may be consi
Public Health & Prevention April 10,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com